Ninth, intraperitoneal administration of AGE-BSA has been reported to impair glucose tolerance in mice in association with decrease in acute insulin secretion [51], AGE may augment foam cell formation of macrophages by further deteriorating hyperglycemia. This evidence concerns the gene INS and Hyperglycemia.